Tocagen's IPO

Tocagen raised a round of funding on April 13, 2017. Investors include Public.

Tocagen is a clinical-stage biopharmaceutical company pursuing the discovery, development, and commercialization of products for the treatment of cancer. Tocagen is initially focusing on treatments fo…

Articles about Tocagen's IPO: